# Deprexil in Subjects With Signs and Symptoms of Depression

> **NCT01043367** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 200 (estimated)

## Conditions studied

- Depression

## Interventions

- **DIETARY_SUPPLEMENT:** Deprexil
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01043367
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01043367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01043367, "Deprexil in Subjects With Signs and Symptoms of Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01043367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*